A rollercoaster ride

Jacobs, Tom

doi:10.1038/nbt0306-284

Investors Lab
Published: 01 March 2006

A rollercoaster ride

Tom Jacobs^na1

Nature Biotechnology volume 24, page 284 (2006)Cite this article

453 Accesses
Metrics details

Access through your institution

Buy or subscribe

If only we knew then, what we know now. Biotech investing has changed over the past ten years in two major ways. First, thanks to fitful bursts of initial public offerings (IPOs), the growth and sheer diversity of companies listed on exchanges has greatly expanded the choices available to investors. And second, the burgeoning number of biopharmaceutical approvals has meant that a few biotech firms have increased in valuation, joining the ranks of the top drug makers and offering investors profitable, sustainable ventures for the first time.

Waves, bubbles and tsunamis

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

Purchase on SpringerLink
Instant access to full article PDF

Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Tom Jacobs is cofounder of Complete Growth Investor, http://www.completegrowth.com, a stock service for individual investors. Tom owned no shares of these companies at time of writing. He welcomes your comments at tom@completegrowth.com.

Authors

Tom Jacobs
View author publications
Search author on:PubMed Google Scholar

Supplementary information

Supplementary Table 1

Top drug makers by enterprise value (2006 and 2001)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacobs, T. A rollercoaster ride. Nat Biotechnol 24, 284 (2006). https://doi.org/10.1038/nbt0306-284

Download citation

Issue date: 01 March 2006
DOI: https://doi.org/10.1038/nbt0306-284